IONIQ Sciences Designated ‘Most Innovative Cancer Detection and Diagnostics Technology Firm’ by CV Magazine

December 14, 2020

12/10/2020 – IONIQ Sciences has been designated as 2020’s ‘Most Innovative Cancer Detection and Diagnostics Technology Firm’ by CV Magazine. Our goal to modernize cancer testing has taken us to exciting heights this year. We resolutely believe in our potential to introduce a ‘breakthrough’ Multi-Cancer Screen that will non-invasively detect the presence of malignancy in its earliest stages utilizing our Electrical Impedance Analytics (EIA) technology and proprietary algorithm. We imagine a future where cancer screening is point-of-care, accurate, and free of radiation. On behalf of the estimated 1.8 million people in the USA diagnosed with cancer in 2020, we’re fighting for this future every day.

Courtesy of IONIQSciences.com